Connect Biopharma Holdings Ltd. (CNTB)
2.07
+0.06
(+2.99%)
USD |
NASDAQ |
Sep 10, 16:00
2.07
0.00 (0.00%)
After-Hours: 20:00
Connect Biopharma Holdings Total Liabilities (Quarterly) : 16.61M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.61M |
| March 31, 2026 | 17.44M |
| December 31, 2025 | 14.10M |
| Date | Value |
|---|---|
| September 30, 2025 | 11.99M |
| June 30, 2025 | 11.38M |
| March 31, 2025 | 9.786M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.47M |
| Shareholders Equity (Quarterly) | 26.86M |
| Debt to Equity Ratio | 0.0222 |
| Current Ratio | 2.369 |
| Net Debt Paydown Yield | 0.05% |